GlassScriptPhysician profile
Patrick Walter Gunn
NPI 1356451447
$1,584.84
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630 · 2020: $374 · 2021: $202 · 2022: $173 · 2023: $183 · 2024: $23.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $362.34 | 2019-2021 | |
| Glaxosmithkline, LLC. | $203.29 | 2019-2023 | Pediarix, Bexsero, Shingrix |
| Sanofi Pasteur INC. | $146.80 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $145.66 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $144.84 | 2019-2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $88.53 | 2019-2023 | |
| Therapeuticsmd, INC. | $81.14 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.88 | 2019-2021 | |
| Abbvie INC. | $47.35 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.11 | 2019 | |
| Adlon Therapeutics L.P. | $46.70 | 2020-2021 | |
| Myovant Sciences INC. | $40.42 | 2022 | |
| Sobi, INC | $39.42 | 2019-2020 | |
| Corium, LLC | $32.14 | 2022-2023 | Azstarys |
| Ultragenyx Pharmaceutical INC. | $20.88 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $17.08 | 2023 | |
| Kaleo, INC. | $17.00 | 2019 | |
| Coopersurgical, INC. | $12.75 | 2019 | |
| Seqirus USA INC | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.